Back to Search
Start Over
Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99.
- Source :
-
Oncotarget [Oncotarget] 2016 Aug 02; Vol. 7 (31), pp. 50535-50547. - Publication Year :
- 2016
-
Abstract
- We investigated the use of cytotoxic T-lymphocyte (CTL) epitopes in peptide immunotherapy for glioblastoma. Three peptides (ERBB2, BIRC5 and CD99) were selected based on their peptide-T2 cell binding affinities and combined in a multipeptide cocktail or a branched multipeptide synthesized with mini-polyethylene glycol spacers. Dendritic cells (DCs) pulsed with the multipeptide cocktail or branched multipeptide were compared based on their immunophenotype and cytokine secretion. FACS analysis of alpha-type 1 polarized dendritic cells (αDC1s) revealed that both groups highly expressed CD80, CD83 and CD86, indicating that both treatments efficiently generated mature αDC1s with the expected phenotype. Production of IL-12p70, IL-12p40 and IL-10 also increased upon αDC1 maturation in both groups. CTLs stimulated by either αDC1 group ("DC-CTLs") included numerous IFN-γ-secreting cells against T2 cells loaded with the corresponding multipeptides. Large numbers of IFN-γ-secreting cells were observed when human glioblastoma cell lines and primary cells were treated with multipeptide-pulsed DC-CTLs. Both multipeptide-pulsed DC-CTL groups exhibited cytotoxic activity of 40-60% against the U251 cell line and 60-80% against primary cells. Branched multipeptide from ERBB2, BIRC5 and CD99 stably bound with T2 cells, and its cytotoxicity toward target cells was similar to that of the multipeptide cocktail. Thus, branched multipeptides could be promising candidates for immunotherapeutic glioblastoma treatment.<br />Competing Interests: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
- Subjects :
- 12E7 Antigen chemistry
Brain Neoplasms immunology
Cell Line, Tumor
Cell Separation
Dendritic Cells immunology
Epitopes, T-Lymphocyte chemistry
Flow Cytometry
Glioblastoma immunology
Humans
Immunophenotyping
Inhibitor of Apoptosis Proteins chemistry
Interferon-gamma metabolism
L-Lactate Dehydrogenase metabolism
Phenotype
Receptor, ErbB-2 chemistry
Survivin
T-Lymphocytes, Cytotoxic cytology
Brain Neoplasms therapy
Glioblastoma therapy
HLA-A2 Antigen chemistry
Immunotherapy methods
Subjects
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 7
- Issue :
- 31
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Academic Journal
- Accession number :
- 27409668
- Full Text :
- https://doi.org/10.18632/oncotarget.10495